Noncontiguous Stage II Mantle Cell Lymphoma Completed Phase Trials for Lithium carbonate (DB14509)

IndicationStatusPhase
DBCOND0028643 (Noncontiguous Stage II Mantle Cell Lymphoma)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00408681Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantSupportive Care